-
A woman died after bleeding on her brain caused by an extremely rare side effect of the COVID-19 vaccine.
-
Kim Lockwood, 34, suffered a severe headache after receiving the AstraZeneca COVID-19 vaccine.
-
Severe and fatal side effects from COVID-19 vaccines are extremely rare, with only 0.0003% of those taking a dose experiencing fatal effects.
A woman has died after a “catastrophic” bleeding on her brain, caused by vaccine-induced thrombotic thrombocytopenia (VITT), an extremely rare side effect of the COVID-19 vaccine, an investigation has heard.
Kim Lockwood, 34, of Rotherham, England, began experiencing terrible headaches eight days after the dose of the AstraZeneca vaccine in March 2021.
When her condition worsened, she was taken to Rotherham Hospital, where she was pronounced dead on March 24, 17 hours later.
This week, the investigation at Doncaster Coroner Court heard that Lockwood originally went to the ER from Rotherham Hospital two days before she died, but without being seen after waiting a long time.
South Yorkshire coroner Nicola Mundy said Lockwood had been “extremely unhappy” and until she was seen there had been no way to help her, the BBC reported.
At the time of Lockwood’s death, there was very sparse information about the relationship between COVID-19 Jab and VITT, Mundy said, adding that now “medical advances” mean the condition is better understood.
Mundy also said Lockwood’s pain was “not properly managed”, saying her and her family’s concerns should be better addressed.
The BBC reported that Lockwood’s father, Wayne Merrill, said his daughter’s last words to him were that her headache “had actually killed her.”
The investigation was a read a family tribute to the mother of two boys: Jayden, 14, and Jax, seven. It describes a “friendly, fun” mom who loves to dance.
After the investigation began, Lockwood’s family said she died of the fright, the BBC reported.
Government data assessing reactions to COVID-19 vaccines show that Lockwood’s response was extremely rare.
To date, the UK government says there have been 438 reported cases of thromboembolic events (blood clots) and 78 deaths after an estimated 24.9 million first doses and 24.2 million second doses of the AstraZeneca vaccine. This corresponds to approximately 0.001% of people taking AstraZeneca vaccine who experience a blood clot and 0.0003% who experience fatal effects.
Recognizing these extremely rare results, a government statement said that vaccination is still “the only effective way to reduce COVID-19 deaths and serious illness.”
People who had COVID-19 were about eight times more likely to have a blood clot on their brain than someone who took the AstraZeneca vaccine.
Clots are extremely rare in both cases, but they occur significantly more frequently in people who have been infected with COVID-19, according to a comparison of two large datasets of experts from the University of Oxford, reports insider Marianne Guenot.
In the UK, 52.7 million people received their first dose of a COVID-19 vaccine, with 49.2 million had their second, UK data show.
38.5 million people had a third or booster dose.
Read the original article on Business Insider
Add Comment